Industry News
Pharmaceutical Industry News
Una alternativa a las gafas: gotas para los ojos
Un tratamiento que puede ayudar a la gente que necesita anteojos para ver de cerca, sin afectar su visión de largo alcance, salió al mercado en diciembre tras ser aprobado por la FDA en octubre.
South Korea approves Pfizer’s coronavirus pill for emergency use.
It is the first pill approved in the nation to treat symptoms of the coronavirus.
Merck, Ridgeback clinch FDA’s 2nd emergency nod for a COVID-19 antiviral pill
Merck, Ridgeback clinch FDA's 2nd emergency nod for a COVID-19 antiviral pill fkansteiner Mon, 12/27/2021 - 09:39
Merck’s Covid Pill Is Authorized by F.D.A. for High-Risk Adults
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
Beneath a Covid Vaccine Debacle, 30 Years of Government Culpability
Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.
Walgreens and CVS Limit Purchases of At-Home Coronavirus Tests
The caps come as the rapid spread of the Omicron variant has customers flocking to testing sites and pharmacies, which are struggling to keep up.
F.D.A. Clears Pfizer’s Covid Pill for High-Risk Patients 12 and Older
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
Pfizer’s megablockbuster-to-be COVID pill Paxlovid scores FDA nod
Pfizer's megablockbuster-to-be COVID pill Paxlovid scores FDA nod esagonowsky Wed, 12/22/2021 - 13:12
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators aliu Wed, 12/22/2021 - 09:18
Particulate problem prompts hold on 10 Gilead studies of HIV hopeful lenacapavir
Particulate problem prompts hold on 10 Gilead studies of HIV hopeful lenacapavir fkansteiner Wed, 12/22/2021 - 09:15
With Sanofi’s mighty Dupixent chasing behind, Takeda’s Eohilia suffers FDA rejection after mysterious delay
With Sanofi's mighty Dupixent chasing behind, Takeda's Eohilia suffers FDA rejection after mysterious delay aliu Wed, 12/22/2021 - 07:41
When medicine is the hero, you need a Sidekick to stay the course
When medicine is the hero, you need a Sidekick to stay the course sharon.coey Wed, 12/22/2021 - 06:32
How to Cope With Medicare’s Rising Costs
A higher Medicare premium in 2022 is just part of the puzzle of health care costs for older Americans. But there are ways to plan.
How to Cope With Medicare’s Rising Costs
A higher Medicare premium in 2022 is just part of the puzzle of health care costs for older Americans. But there are ways to plan.
Girding for BMS competition, Amgen wins another plaque psoriasis nod for Otezla
Girding for BMS competition, Amgen wins another plaque psoriasis nod for Otezla kdunleavy Tue, 12/21/2021 - 11:24
AbbVie, after losing Humira trade secrets case, eyes new strategy in Alvotech fight
AbbVie, after losing Humira trade secrets case, eyes new strategy in Alvotech fight fkansteiner Tue, 12/21/2021 - 11:00
GlaxoSmithKline’s HIV prevention injectable Apretude threatens Gilead with FDA blessing. But will doctors use it?
GlaxoSmithKline’s HIV prevention injectable Apretude threatens Gilead with FDA blessing. But will doctors use it? aliu Tue, 12/21/2021 - 10:34
Amgen to spend $100M to build new vial filling line at Dublin site: report
Amgen to spend $100M to build new vial filling line at Dublin site: report jkeenan Tue, 12/21/2021 - 09:47
Turkish biotech bags $12M for targeted delivery of cancer drugs
Turkish biotech bags $12M for targeted delivery of cancer drugs ntaylor Tue, 12/21/2021 - 09:28
Novo pumps $97.1M into Danish bioproduction startup 21st.BIO
Novo pumps $97.1M into Danish bioproduction startup 21st.BIO jkeenan Tue, 12/21/2021 - 09:05